Most valuation professionals learn valuing healthy, stable businesses. But when a company’s finances start to unravel, shrinking margins, mounting debt, a cash position that keeps getting thinner, the rules change.
The Professional Framework
Distressed valuation doesn’t operate in a vacuum. Practitioners are expected to work within a web of standards. Valuation shows up throughout the distress lifecycle: advising clients on divesting business units to raise liquidity, advising creditors on the value of distressed claims, supporting M&A and estate planning, and determining reorganization value, evaluating plans of reorganization, running liquidation analyses, and testing solvency for potential recovery actions once a company reaches bankruptcy.
The mechanics of any valuation still start with the fundamentals: defining the legal interest being valued, understanding ownership characteristics like control and marketability, pinning down the valuation date, and identifying the right standard and premise of value. What changes in a distressed context is how much weight and scrutiny each of these decisions carries.
Spotting Distress Before It’s Obvious
Distress usually announces itself in the numbers. On the balance sheet, weakening cash position, insufficient working capital, rising debt, and swelling fixed assets. On the income statement, declining sales, shrinking margins, creeping overhead, and a consistent gap between actual and budgeted performance. Underperformance relative to industry peers is another red flag. The root causes of distress tend to fall into a few buckets: poor management, external pressure, and poor financial operations.
Cost of Capital: A Different Calculation
Distressed companies have a fundamentally different capital structure problem, often one that’s non-sustainable in its current form. Standard tools still apply, but require adjustments for size, company-specific risk, and industry comparables.
Beta is a particular challenge: a distressed company’s own historical beta is often unreliable, pushing analysts toward guideline-company or fundamental betas instead. That comes with its own caveat — if an entire industry is under pressure, guideline companies may not offer a clean read on risk, and even healthy comparables may need an added risk adjustment to reflect the subject company’s distress.
Discount rate calculations also get more complicated. A single, static weighted average cost of capital often doesn’t hold up if the company’s leverage is expected to shift, which is frequently the case in a turnaround or reorganization. For reorganization valuations specifically, the actual debt level contemplated in the reorganization plan should drive the analysis, and venture capital benchmarking, normally reserved for high-risk startups, can sometimes offer a useful reference point for distressed companies as well.
Adjusting the Income Approach
A distressed company’s projected cashflow needs more scrutiny than a healthy company’s cashflow. Analysts should ask hard questions: Why were historical revenues depressed? How is the balance sheet expected to change? If forecasts show a turnaround, what’s driving that improvement, and is it credible? Unique costs specific to distress, including restructuring and professional fees, the cost of restarting operations, and lost customers tied to negative publicity, all need to be built into the forecast. On the balance sheet side, working capital assumptions should reflect abnormal conditions like stretched payables or depleted inventory, capex may need to account for deferred maintenance, and tax treatment should factor in net operating losses, and cancellation-of-debt income. Discount rates typically need additional risk premiums, and analysts should consider truncating the cash flow projection entirely if there’s real risk the company won’t survive as a going concern.
Adjusting the Market Approach
Guideline company and transaction methods remain useful but require real judgment. If an entire industry is under pressure, the “comparable” companies may not be so comparable after all. General market sentiment can distort observed multiples in either direction. Importantly, distress doesn’t automatically mean a company deserves the lowest multiple in its peer set; the adjustment should reflect the company’s specific circumstances rather than a blanket discount. When using precedent transactions, analysts should dig into deal structure, consider the buyer type, and whether the target itself needed a capital injection to get the deal done.
Adjusting the Asset Approach
For companies facing liquidation, a net asset value or liquidation analysis serves as a “floor value”. Essentially, what would be left after selling all assets and settling liabilities. This requires estimating realistic recovery rates by asset type, factoring in whether a sale would be orderly or forced, and deducting wind-down costs such as severance, environmental remediation, retention bonuses, and professional fees. In bankruptcy specifically, this ties into the priority of claims, and can involve court-approved sales of assets.
Reconciling the Analysis
Whatever methods are used, the final step is a reality check: what could cause this company not to succeed? Common risk factors include a management team unable to execute its own strategic plan, a fundamentally uncompetitive cost structure, excessive leverage, unrealistic projections, or working capital shortages that simply can’t be resolved. These probability-weighted considerations belong in the value reconciliation, not just the discount rate.
Other Considerations
A few additional technical points round out the picture. Solvency testing differs depending on context. Outside of bankruptcy, it’s largely a balance-sheet exercise. While inside bankruptcy, there’s a presumption of insolvency for transactions in the 90 days preceding the petition date, extendable further for insider transactions, which creditors can challenge. Ownership changes can also trigger net operating loss limitations, sometimes requiring iterative calculations to work through. Companies emerging from Chapter 11 may apply fresh-start reporting, effectively treating the reorganized business as a new entity with reorganization value as its accounting basis.
What should I Do?
Hire an expert (like us). Valuing a distressed business is rarely a matter of running the same models with slightly gloomier inputs. It requires blending all three valuation approaches, making and rigorously supporting case-specific adjustments for distress, stress-testing conclusions with scenario analysis, and being prepared to defend every assumption under scrutiny, whether from opposing experts, creditors, or a bankruptcy judge. Distressed entities bring genuinely different challenges than healthy ones, and a credible valuation expert has to reflect that at every step